Probiotics have been used in the treatment of
CDAD, but their role remains uncertain.
Furthermore, our considerations regarding the application of pro-/prebiotics in distinctive intestinal conditions of the elderly (i.e., constipation and
CDAD) underscore the necessity to enhance the very limited clinical evidence confirming its efficacy in prevention and especially treatment of these pathologies (amply quoted in [66]).
In a human gut model of
CDAD, cadazolid was found to have a very limited impact on the normal gut microflora.
difficile toxin A and B using enzyme-linked fluorescent assay to identify
CDAD. By adopting a nested case- control design, the matched people (ratio 1:3) without AAD were included as controls.
It has been reported that prolonged length of stay in the healthcare settings and presence of other illnesses contribute to
CDAD. [5]
Conversely, a 2008 review of 4 studies (N=336) concluded there is insufficient evidence for using probiotics to treat
CDAD, either as monotherapy or adjunct therapy.
difficile-associated disease (
CDAD) represents a constellation of illnesses caused by the C.
Clostridium difficile-associated diarrhea (
CDAD) is possibly one of the most important examples in vivo on how antibiotics affect the resident microbial ecosystem patient health.
One of the worst consequences of antibiotic use is a vicious diarrhea known medically as "C diff colitis" or "C difficile-associated diarrhea (
CDAD)." About three percent of people carry C.
* Prevention of Clostridium difficile-associated diarrhea (
CDAD)
difficile multiplication and development, facilitated by dysbiosis, are necessary for
CDAD [31, 32].
difficile associated disease (
CDAD), as previously reported (3).